Journal article · 2009 · Open access

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia

Andrea Cipriani, Marianna Boso, Corrado Barbui

Cochrane Database of Systematic Reviews, CD006324 · Published 3 July 2009 · DOI 10.1002/14651858.cd006324.pub2

Open full textView at the publisherCite this paper

In brief

“Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia” is a 2009 journal article by Andrea Cipriani and 2 co-authors, published in Cochrane Database of Systematic Reviews. OpenAlex counts 95 citations as of 20 November 2026. It is open access: the full text is free to read at Europe PMC (PubMed Central).

Citations
95
Most cited in
2017 (5)
References
50
Authors
3

Abstract

BACKGROUND: Although clozapine has been shown to be the treatment of choice in people with schizophrenia that are resistant to treatment, one third to two thirds of people still have persistent positive symptoms despite clozapine monotherapy of adequate dosage and duration. The need to provide effective therapeutic interventions to patients who do not have an optimal response to clozapine is the most common reason for simultaneously prescribing a second antipsychotic drug in combination with clozapine. OBJECTIVES: To determine the efficacy and tolerability of various clozapine combination strategies with antipsychotics in people with treatment resistant schizophrenia. SEARCH STRATEGY: We searched the Cochrane Schizophrenia Group Trials Register (March 2008) and MEDLINE (up to November 2008). We checked reference lists of all identified randomised controlled trials and requested pharmaceutical companies marketing investigational products to provide relevant published and unpublished data. SELECTION CRITERIA: We included only randomised controlled trials recruiting people of both sexes, aged 18 years or more, with a diagnosis of treatment-resistant schizophrenia (or related disorders) and comparing clozapine plus another antipsychotic drug with clozapine plus a different antipsychotic drug. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data and resolved disagreement by discussion with third member of the team. When insufficient data were provided, we contacted the study authors. MAIN RESULTS: Three small (range of number of participants 28 to 60) randomised controlled trials were included in the review. Even though results from individual studies did not find that one combination strategy is better than the others, the methodological quality of included studies was too low to allow authors to use the collected data to answer the research question correctly. AUTHORS' CONCLUSIONS: In this review we considered the risk of bias too high because of the poor quality of the retrieved information (small sample size, heterogeneity of comparisons, flaws in the design, conduct and analysis). Although clinical guidelines recommend a second antipsychotic in addition to clozapine in partially responsive patients with schizophrenia, the present systematic review was not able to show if any particular combination strategy was superior to the others. New, properly conducted, randomised controlled trials independent from the pharmaceutical industry need to recruit many more patients to give a reliable estimate of effect or of no effect of antipsychotics as combination treatment with clozapine in patients who do not have an optimal response to clozapine monotherapy.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Cipriani, A., Boso, M., & Barbui, C. (2009). Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia. Cochrane Database of Systematic Reviews, CD006324. https://doi.org/10.1002/14651858.cd006324.pub2

MLA 9

Cipriani, Andrea, et al. “Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.” Cochrane Database of Systematic Reviews, no. 3, 2009, p. CD006324. https://doi.org/10.1002/14651858.cd006324.pub2.

Chicago

Cipriani, Andrea, Marianna Boso, and Corrado Barbui. 2009. “Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.” Cochrane Database of Systematic Reviews (3): CD006324. https://doi.org/10.1002/14651858.cd006324.pub2.

Harvard

Cipriani, A., Boso, M. and Barbui, C. (2009) ‘Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia’, Cochrane Database of Systematic Reviews, p. CD006324. doi:10.1002/14651858.cd006324.pub2.

IEEE

A. Cipriani, M. Boso, and C. Barbui, “Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia,” Cochrane Database of Systematic Reviews, no. 3, p. CD006324, 2009, doi: 10.1002/14651858.cd006324.pub2.

BibTeX

@article{cipriani2009clozapine,
  title     = {{Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia}},
  author    = {Cipriani, Andrea and Boso, Marianna and Barbui, Corrado},
  journal   = {Cochrane Database of Systematic Reviews},
  year      = {2009},
  number    = {3},
  pages     = {CD006324},
  doi       = {10.1002/14651858.cd006324.pub2},
  url       = {https://doi.org/10.1002/14651858.cd006324.pub2}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201755
201833
201955
202033
202144
202244
202344
202422
202533
202611

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • clozapine
  • treatment-resistant schizophrenia
  • antipsychotic polypharmacy
  • treatment response
  • tolerability
  • risk of bias

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Cipriani, A., Boso, M., & Barbui, C. (2009). Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia. Cochrane Database of Systematic Reviews, CD006324. https://doi.org/10.1002/14651858.cd006324.pub2

How many times has this paper been cited?

95 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Europe PMC (PubMed Central): sign in and open the full text from this page.

Who wrote this paper?

Andrea Cipriani, Marianna Boso, Corrado Barbui.

What is the DOI of this paper?

10.1002/14651858.cd006324.pub2, permanently at https://doi.org/10.1002/14651858.cd006324.pub2. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.